BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling

GLIA

Volumn 46, Issue 3, 2004, Pages 284-295

  Brito, Veronica ^a   Beyer, Cordian ^a   Küppers, Eva ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Astroglia; BDNF; Development; Dopamine receptor; Striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 5 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; DOPAMINE 1 RECEPTOR; DRD5 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL INTERACTION; CONFOCAL LASER MICROSCOPY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO DEVELOPMENT; FLUORESCENCE ACTIVATED CELL SORTING; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; EMBRYO; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CORPUS STRIATUM; EMBRYO; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; SIGNAL TRANSDUCTION;

EID: 2442677972     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10356     Document Type: Article

References (50)

1. Bal A, Bachelot T, Savasta M, Manier M, Verna, JM, Benabid AL, Feuerstein C. 1994. Evidence for D2DR mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Mol Brain Res 23:204-212.
2. Baufreton J, Garret M, Rivera A, de la Calle A, Gonon F, Dufy B, Bioulac B, Taupignon A. 2003. D5 (not D1) dopamine receptors potentate burst-firing in neurons of the subthalamic nucleus by modulating and L-type calcium conductance. J Neurosci 1:23:816-25.
3. Bezzi P, Domercq M, Vesce S, Volterra A. 2001. Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog Brain Res 132:255-265.
4. Butler AK, Uryu K, Chesselet MF. 1998. A role for N-methyl-D-aspartate receptors in the regulation of synaptogenesis and expression of the polysialylated form of the neural cell adhesion molecule in the developing striatum. Dev Neurosci 20:253-262.
5. Constantini LC, Feinstein SC, Radeke MJ, Snyder-Keller A. 1999. Compartmental expression of trkB receptor protein in the developing striatum. Neuroscience 89:505-513.
6. Gates MA, Dunnett SB. 2001. The influence of astrocytes on the development, regeneration and reconstruction of the nigrostriatal dopamine system. Restor Neurol Neurosci 19:67-83.
7. Grandy DK, Allen LJ, Zhang Y, Bouvier C, Zhou Q-Y, Jonhson RA, Allen L, Buck K, Bunzow JR, Salon J, Civelli O. 1991. Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci USA 88:9175-1979.
8. Granholm AC, Reyland M, Albeck D, Sanders L, Gerhardt G, Hoernig G, Shen L, Westphal H, Hoffer B. 2000. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain neurons. J Neurosci 20:3182-3190.
9. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. 2001. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86-89.
10. Hansson E, Rönnbäck L. 1988. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor. Glia 1:393-397.
11. Hatten ME, Mason CA. 1986. Neuron-astroglia interactions in vitro and in vivo. Trends Neurosci 9:168-174.
12. Hazell AS, Itzhak Y, Liu H, Norenberg MD. 1997. 1-Methyl-4-phenyl-1,2,3,6-tetrahydrobiopterin (MPTP) decreases glutamate uptake in cultured astrocytes. J Neurochem 68:2216-2219.
13. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
14. Ivanova T, Küppers E, Engele J, Beyer C. 2001. Estrogen stimulates brain-derived neurotrophic factor in embryonic mouse midbrain neurons through a membrane-mediated and calcium-dependent mechanism. J Neurosci Res 66:221-230.
15. Ivanova T, Karolczak, M, Beyer C. 2002. Estrogen stimulates GDNF expression in developing hypothalamic neurons. Endocrinology 143:3175-3178.
16. Ivanova T, Beyer C. 2003. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J Neurobiol 54:638-674.
17. Jain M, Armstrong RJ, Barker RA, Rosser AE. 2001. Cellular and molecular aspects of striatal development. Brain Res Bull 55:533-540.
18. Kinor N, Geffen R, Golomb E, Zinman T, Yadid G. 2001. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33:143-150.
19. Küppers E, Beyer C. 1998. Expression of aromatase in the embryonic and postnatal mouse striatum. Mol Brain Res 63:184-188.
20. Küppers E, Beyer C. 2001. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. NeuroReport 12:1175-1179.
21. Küppers E, Sabolek M, Anders U, Pilgrim C, Beyer C. 2000. Developmental regulation of glutamic acid decarboxylase mRNA expression and splicing in the rat striatum by dopamine. Mol Brain Res 81:19-28.
22. Lachvankar MB, Condon PJ, Quesenberry PJ, Litofski NS, Recht LD, Ross AH. 1997. Embryonic precursor cells that express TrK receptors: induction of different cell fates by NGF, BDNF, NT-3, and CNTF. Exp Neurol 144:350-360.
23. Lezcano N, Bergson C. 2002. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 87:2167-2175.
24. Liu F, Graybiel AM. 1998. Activity-regulated phosphorylation of cAMP response element binding protein in the developing striatum: implications for patterning the neurochemical phenotypes of striatal compartments. Dev Neurosci 20:229-236.
25. Lopez-Martin E, Caruncho HJ, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. 1999. Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal striatal grafts. J Comp Neurol 406:199-206.
26. Luk KC, Kennedy TE, Sadikot AF. 2003. Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism. J Neurosci 23:2239-2250.
27. Mizuno K, Carnahan J, Nawa H. 1994. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165:243-256.
28. Müller HW, Junghans U, Kappler J. 1995. Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther 65:1-18.
29. Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, Sakurai T, Nishino H. 2001. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res 916:76-84.
30. Nawa H, Pelleymounter MA, Carnahan J. 1994. Intraventricular administration of BDNF increases neuropeptide expression in newborn rats. J Neurosci 14:3751-3765.
31. Ortuno-Sahagun D, Beas-Zarate C, Adame-Gonzalez G, Feria-Velasco A. 1997. Effect of L-glutamate on cholinergic neurotransmission in various brain regions and during the development of rats, when administered perinatally. Neurochem Int 31:683-692.
32. Parpura V, Haydon PG. 2000. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA 97:8629-8634.
33. Polymeropoulos MH, Xiao H, Merril CR. 1991. The human D5 dopamine receptor (D5DR) maps on chromosome 4. Genomics 11:777-778.
34. Reisert I, Schuster R, Zienecker R, Pilgrim C. 1990. Prenatal development of mesencephalic and diencephalic dopaminergic systems in the male and female rat. Dev Brain Res 53:222-229.
35. Reuss B, Unsicker K. 2000. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells. Mol Cell Neurosci 16:781-792
36. Rosser AE, Tyers P, Dunnett SB. 2000. The morphological development of neurons derived from EGF- and FGF-2 driven human CNS progenitors depends on their site of integration in the neonatal rat brain. Eur J Neurosci 12:2405-2413.
37. Schambra U, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT. 1994. Ontogeny of D1a and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62:65-85.
38. Schmidt U, Beyer C, Oestreicher AB, Reisert I, Schilling K, Pilgrim C. 1996. Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons. Neuroscience 74:453-460.
39. Schmidt U, Pilgrim C, Beyer C. 1998. Differentiative effects of dopamine on striatal neurons involve stimulation of the cAMP/PKA pathway. Mol Cell Neurosci 11:9-18.
40. Stadlin A, Lau JW, Szeto YK. 1998. A selective regional response of cultured astrocytes to methamphetamine. Ann NY Acad Sci 30:108-121.
41. Tang K, Low MJ, Grandy DK, Lovinger DM. 2001. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 98:1255-1260.
42. Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N, Bertrand L, Yang-Feng TL, Fremeau RT Jr, Caron MG. 1991. Cloning, molecule characterization, and chromosomal assignment of a gene encoding a second D-1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D-1A receptor. Proc Natl Acad Sci USA 88:7491-7495.
43. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
44. Ventimiglia R, Mather PE, Jones BE, Lindsay RM. 1995. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7:213-222.
45. Vesce S, Bezzi P, Volterra A. 2001. Synaptic transmission with the glia. News Physiol Sci 16:178-184.
46. Ward NL, Hagg T. 2000. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp Neurol 162:297-310.
47. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S. 1994. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
48. Zaheer A, Yorek MA, Lim R. 2001. Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochem Res 26:1293-1299.
49. Zanassi P, Paolilla A, Montecucco A, Avvedimento EV, Schinelli S. 1999. Pharmacological and molecular evidence for dopamine D1 receptor expression by striatal astrocytes in culture. J Neurosci Res 58:544-552.
50. Zhou QY, Palmiter RD. 1995. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.